Authors:
Culham, DE
Lu, A
Jishage, M
Krogfelt, KA
Ishihama, A
Wood, JM
Citation: De. Culham et al., The osmotic stress response and virulence in pyelonephritis isolates of Escherichia coli: contributions of RpoS, Prop, ProU and other systems, MICROBI-SGM, 147, 2001, pp. 1657-1670
Authors:
Levitt, NC
Eskens, FALM
O'Byrne, KJ
Propper, DJ
Denis, LJ
Owen, SJ
Choi, L
Foekens, JA
Wilner, S
Wood, JM
Nakajima, M
Talbot, DC
Steward, WP
Harris, AL
Verweij, J
Citation: Nc. Levitt et al., Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer, CLIN CANC R, 7(7), 2001, pp. 1912-1922
Citation: Jm. Wood et K. Mallon, Comparison of driving performance of young and old drivers (with and without visual impairment) measured during in-traffic conditions, OPT VIS SCI, 78(5), 2001, pp. 343-349
Authors:
Wood, JM
Nezworski, MT
Garb, HN
Lilienfeld, SO
Citation: Jm. Wood et al., The misperception of psychopathology: Problems with the norms of the Comprehensive System for the Rorschach, CL PSYCH-SC, 8(3), 2001, pp. 350-373
Authors:
Wood, JM
Nezworski, MT
Garb, HN
Lilienfeld, SO
Citation: Jm. Wood et al., Problems with the norms of the Comprehensive System for the Rorschach: Methodological and conceptual considerations, CL PSYCH-SC, 8(3), 2001, pp. 397-402
Authors:
Gasser, RB
Woods, WG
Wood, JM
Ashdown, L
Richards, G
Whithear, KG
Citation: Rb. Gasser et al., Automated fluorescence-based approach for the specific diagnosis of chicken coccidiosis, ELECTROPHOR, 22(16), 2001, pp. 3546-3550
Authors:
Wood, JM
Lilienfeld, SO
Nezworski, MT
Garb, HN
Citation: Jm. Wood et al., Coming to grips with negative evidence for the comprehensive system for the Rorschach: A comment on Gacono, Loving, and Bodholdt; Ganellen; and Bornstein, J PERS ASSE, 77(1), 2001, pp. 48-70
Authors:
Wood, JM
Nezworski, MT
Stejskal, WJ
Garven, S
Citation: Jm. Wood et al., Advancing scientific discourse in the controversy surrounding the comprehensive system for the Rorschach: A rejoinder to Meyer (2000), J PERS ASSE, 76(3), 2001, pp. 369-378
Authors:
Schallreuter, KU
Moore, J
Wood, JM
Beazley, WD
Peters, EMJ
Marles, LK
Behrens-Williams, SC
Dummer, R
Blau, N
Thony, B
Citation: Ku. Schallreuter et al., Epidermal H2O2 accumulation alters tetrahydrobiopterin (6BH(4)) recycling in vitiligo: Identification of a general mechanism in regulation of all 6BH(4)-dependent processes?, J INVES DER, 116(1), 2001, pp. 167-174
Citation: Ki. Racher et al., Requirements for osmosensing and osmotic activation of transporter ProP from Escherichia coli, BIOCHEM, 40(24), 2001, pp. 7324-7333
Authors:
Rahuel, J
Rasetti, V
Maibaum, J
Rueger, H
Goschke, R
Cohen, NC
Stutz, S
Cumin, F
Fuhrer, W
Wood, JM
Grutter, MG
Citation: J. Rahuel et al., Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin, CHEM BIOL, 7(7), 2000, pp. 493-504
Authors:
Culham, DE
Tripet, B
Racher, KI
Voegele, RT
Hodges, RS
Wood, JM
Citation: De. Culham et al., The role of the carboxyl terminal alpha-helical coiled-coil domain in osmosensing by transporter ProP of Escherichia coli, J MOL RECOG, 13(5), 2000, pp. 309-322
Authors:
Bold, G
Altmann, KH
Frei, J
Lang, M
Manley, PW
Traxler, P
Wietfeld, B
Bruggen, J
Buchdunger, E
Cozens, R
Ferrari, S
Furet, P
Hofmann, F
Martiny-Baron, G
Mestan, J
Rosel, J
Sills, M
Stover, D
Acemoglu, F
Boss, E
Emmenegger, R
Lasser, L
Masso, E
Roth, R
Schlachter, C
Vetterli, W
Wyss, D
Wood, JM
Citation: G. Bold et al., New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis (vol 43, pg 2316, 2000), J MED CHEM, 43(16), 2000, pp. 3200-3200
Authors:
Bold, G
Altmann, KH
Frei, J
Lang, M
Manley, PW
Traxler, P
Wietfeld, B
Bruggen, J
Buchdunger, E
Cozens, R
Ferrari, S
Furet, P
Hofmann, F
Martiny-Baron, G
Mestan, J
Rosel, J
Sills, M
Stover, D
Acemoglu, F
Boss, E
Emmenegger, R
Lasser, L
Masso, E
Roth, R
Schlachter, C
Vetterli, W
Wyss, D
Wood, JM
Citation: G. Bold et al., New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis, J MED CHEM, 43(12), 2000, pp. 2310-2323